Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0900
+0.0100 (12.50%)
Aug 10, 2026, 1:44 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 24.65 million as of August 10, 2026. Its market cap has increased by 182.78% in one year.
Market Cap
24.65M
Enterprise Value
21.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 24.65M, an increase of 41.59%. That is a compound annual growth rate of 4.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 24.65M | 103.30% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sona Nanotech | 38.32M |
| Telescope Innovations | 34.76M |
| Medicenna Therapeutics | 34.61M |
| Resverlogix | 32.66M |
| Quantum BioPharma | 30.78M |
| Defence Therapeutics | 30.32M |
| Thiogenesis Therapeutics | 28.51M |
| Sharp Therapeutics | 27.37M |